Grail (GRAL) Net Income towards Common Stockholders (2023 - 2026)
Grail (GRAL) posted Net Income towards Common Stockholders of -$93.2 million for Q1 2026, up 6.04% quarter-over-quarter from -$99.2 million in Q4 2025, and up 12.26% year-on-year from -$83.0 million in Q1 2025.
Grail (GRAL) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Net Income towards Common Stockholders for 4 consecutive years, with -$93.2 million the latest figure, recorded in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$93.2 million, up 12.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$395.3 million (up 79.35% YoY), and the FY2025 annual result was -$408.4 million, up 79.85% from the prior year.
- Net Income towards Common Stockholders was -$93.2 million for Q1 2026 at Grail, up from -$99.2 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$89.0 million in Q3 2025 and troughed at -$1.6 billion in Q2 2024.
- Average Net Income towards Common Stockholders over 4 years is -$316.7 million, with a median of -$119.8 million recorded in 2024.
- Year-over-year, Net Income towards Common Stockholders sank 721.23% in 2024 and soared 92.81% in 2025.
- Over 4 years, Net Income towards Common Stockholders stood at -$187.5 million in 2023, then soared by 48.24% to -$97.1 million in 2024, then decreased by 2.17% to -$99.2 million in 2025, then increased by 6.04% to -$93.2 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$93.2 million in Q1 2026, -$99.2 million in Q4 2025, and -$89.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Grail | 2.77 Bn | 1.94 Bn | 10.12 Mn | -93.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.19 Mn |
| Dec 31, 2025 | -99.18 Mn |
| Sep 30, 2025 | -88.98 Mn |
| Jun 30, 2025 | -113.99 Mn |
| Mar 31, 2025 | -106.21 Mn |
| Dec 31, 2024 | -97.07 Mn |
| Sep 30, 2024 | -125.69 Mn |
| Jun 30, 2024 | -1.59 Bn |
| Mar 31, 2024 | -218.91 Mn |
| Dec 31, 2023 | -187.53 Mn |
| Oct 1, 2023 | -891.45 Mn |
| Jun 30, 2023 | -193.04 Mn |